Blocking CCL5/RANTES–CCR5 by genetic deletion or ICV injection of an antagonist inhibited hypothalamic insulin signaling and insulin resistance, indicating that this chemokine has a role in suppressing S6K-mediated negative feedback input to insulin signaling. The gene discussed is RPS6KB1; the disease is Insulin resistance.